Omalizumab Break Tied to Urticaria Relapse Risk in Teens

Relapse after discontinuing omalizumab is common in adolescents with chronic spontaneous urticaria, with early onset of disease and longer duration of pretreatment symptoms linked to recurrence.
Medscape Medical News

source https://www.medscape.com/viewarticle/omalizumab-break-tied-urticaria-relapse-risk-teens-2025a1000qvp?src=rss